TB Research

CD4+ AND CD8+ T-CELLS EXPRESSING INTERFERON GAMMA IN ACTIVE PULMONARY TUBERCULOSIS PATIENTS

Tambunan BA, Priyanto H, Nugraha J, Soedarsono

African journal of infectious diseases · 2018-03

Abstract

Background Tuberculosis (TB) is a global health problem. Immune response through CD4 + and CD8 + T cells is needed to produce Interferon gamma (IFN-γ), a cytokine eliminate Mycobacterium tuberculosis . We aimed to compare the cellular immune response based on the percentage of CD4 + and CD8 + T cells expressing interferon gamma in active pulmonary tuberculosis patients before and after 2 months of tuberculosis treatment. Methods It is a longitudinal cohort study included 12 patients with new active pulmonary TB of the Pulmonary Hospital, Surabaya. The CD4 + and CD8 + T cells expressing interferon gamma was measured by flow cytometry method. Results The mean CD4 + interferon gamma percentage of new active pulmonary TB before treatment was higher than 2 months after tuberculosis treatment (4.48% vs. 1.52%) and there was a significantly decreased ( p = 0.025). The mean CD8 + interferon gamma percentage of new active pulmonary TB before treatment was higher than 2 months after tuberculosis treatment (3.56% vs. 2.89%) but not significantly decreased ( p = 0.186). Conclusions The mean CD4 + IFN-γ percentage of new active pulmonary TB before treatment was higher than 2 months after treatment, suggesting that CD4 + T cells expressing IFN-γ play a role in protection against pulmonary TB infection.